Top Banner
VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto
150

VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Dec 27, 2015

Download

Documents

Barnaby Miles
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

VASCULAR/INTERVENTIONALDr. Jeff Jaskolka

University of Toronto

Page 2: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Disclosure:

Have acted as consultant for:SiemensBraccoLantheusNo bearing on the contents of this lecture

Some uses of devices shown are “off-label”

Page 3: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

DISCLAIMER:VIR not the same as diagnosticWe are simple folkFocus on management, diagnoses straightforward

Page 4: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASES

Page 5: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 148 year old woman with hypertension

11

Page 6: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 7: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Best treatment?

Would you use a stent?

11

Page 8: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 255 year old woman with hypertension

22

Page 9: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 10: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Best treatment?

Would you use a stent?

22

Page 11: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 375 year old male with right leg claudication

33

Page 12: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

RAO LAO

Page 13: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Best treatment?

If endovascular treatment, would you use a stent?

33

Page 14: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 477 year old male, left leg claudication

44

Page 15: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 16: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Best treatment?

What would you use for endovascular treatment?

44

Page 17: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 535 year old female, pain after eating

55

Page 18: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Sagittal CTA Coronal CTA

Page 19: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Provocative manouver?

Best treatment?

55

Page 20: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE REVIEW

Page 21: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Case 1: FIBROMUSCULAR DYSPLASIA (BILATERAL)

11

Page 22: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Gadolinium enhanced MRA

Coronal MIP

Axial MIP

Page 23: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 24: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Atherosclerosis

Standing waves

Vasculitis

1

Presentation Title - Subtitle

Page 25: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

NOTABLE:

more common in women, 65% bilateral

CLASSIC DESCRIPTOR:

“String of beads” appearance of renal artery

+/- webs

+/- stenosis

PEARL:

mid/distal renal artery vs. ostial/proximal 1/3

5 types, medial fibroplasia (type II) most common

1

Presentation Title - Subtitle

Page 26: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

TREATMENT:

endovascular preferred

angioplasty alone, no stent

1

Presentation Title - Subtitle

Page 27: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

22

Case 2: RENAL ARTERY STENOSIS(ATHEROSCLEROTIC)

Page 28: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Frontal aortogram Left renal arteriogram post treatment

Page 29: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Vasculitis

Fibromuscular dysplasia

Congenital

2

Presentation Title - Subtitle

Atherosclerosis

Atherosclerosis

Atherosclerosis

Page 30: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points2

Presentation Title - Subtitle

NOTABLE:

<10% cases of hypertension due to RAS

CLASSIC DESCRIPTOR:

Eccentric, ostial narrowing of renal artery with associated atherosclerotic aorta

PEARL:

>50% stenosis or >10% systolic pressure drop across lesion considered hemodynamically significant

Page 31: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

TREATMENT:

MEDICAL

endovascular treatment for:

failed medical therapy

renal salvage (ie. renal failure)

flash pulmonary edema

endovascular treatment is primary stent

balloon expandable for high radial force and accuracy of placement

2

Presentation Title - Subtitle

Page 32: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

33

Case 3: EXTERNAL ILIAC ARTERY STENOSIS

Page 33: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Atherosclerosis

Atherosclerosis

Atheroscelrosis(trauma/iatrogenic, vasculitis)

3

Presentation Title - Subtitle

Page 34: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

RAO arteriogram LAO arteriogram

Page 35: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 36: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points3

Presentation Title - Subtitle

NOTABLE:

common cause of unilateral claudication

CLASSIC DESCRIPTOR:

focal, short, eccentric stenosis

PEARL:

best, most durable treatment for all iliac lesions is surgical bypass

Page 37: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

TREATMENT:

best treatment is surgical bypass

many patients not candidates

multiple comorbidities

best lesions for angioplasty

concentric

short

non-calcified

stenting in external iliac artery optional

self expanding stent best

3

Presentation Title - Subtitle

Page 38: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

44

Case 4: AORTOILIAC STENOSIS

Page 39: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

No differential

4

Presentation Title - Subtitle

Page 40: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 41: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 42: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points4

Presentation Title - Subtitle

NOTABLE:

iliac bifurcation lesions extension of aortic disease

CLASSIC DESCRIPTOR:

bilateral calcified narrowing of iliac bifurcation

PEARL:

Treatment is with “kissing” balloons or stents

Page 43: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

TREATMENT:Aortobiiliac or aortobifemoral bypass graft

most durableEndovascular

kissing stents/balloons for simultaneous treatment of both sides or to protect unaffected side from

occlusion/dissectionballoon vs. self expanding stents

higher radial force, precise position

4

Presentation Title - Subtitle

Page 44: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

55

Case 5: MEDIAN ARCUATE LIGAMENT SYNDROME

Page 45: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Sagittal CTA Coronal CTA

Page 46: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Atherosclerosis

Vasculitis

Extrinsic compression (not truly median arcuate ligament “syndrome”)

5

Presentation Title - Subtitle

Page 47: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points5

Presentation Title - Subtitle

NOTABLE:

extrinsic compression of celiac axis by median arcuate ligament

CLASSIC DESCRIPTOR:

J-shaped appearance of proximal celiac artery

PEARL:

stenosis gets worse with expiration

treatment is conservative or surgical. Endovascular treatment not appropriate

Page 48: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points – OPENING

Presentation Title - Subtitle

Not all lesions require treatment

Angioplasty is not the only treatment

Best lesions for angioplasty:

- short, concentric, non-calcified

Stenting for bailout, ostial lesions

Balloon expanding stents - ostial lesions

Self expanding stents – flexible/mobile anatomy

Page 49: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASES

Page 50: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 665 year old female, bruising 4 days post cardiac catheterization

66

Page 51: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Right groin doppler

Page 52: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Best treatment?

What would you use for endovascular treatment?

33

Page 53: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 750 year old male found unconscious with hematochezia

77

Page 54: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 55: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Best treatment?

What would you use for endovascular treatment?

77

Page 56: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 880 year old male, routine f/u post EVAR

88

Page 57: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 58: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Does this need treatment?

If so, what would treatment be?

33

Page 59: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 970 year old female with massive hemoptysis

99

Page 60: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 61: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Treatment options?

What is the most devastating potential complication of endovascular treatment?

99

Page 62: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 1034 year old man with scrotal mass

1010

Page 63: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

4mm

Page 64: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Treatment options?

What would you use for endovascular treatment?

1010

Page 65: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE REVIEW

Page 66: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

66

Case 6: COMMON FEMORAL ARTERY PSEUDOANEURYSM

Page 67: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

True aneurysm

Mycotic aneurysm

Arteriovenous fistula

6

Presentation Title - Subtitle

Page 68: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Right groin doppler

Page 69: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Needle tip

Page 70: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points6

Presentation Title - Subtitle

NOTABLE:

Common complication of femoral artery complication.

Presents with bruising, palpable lump

CLASSIC DESCRIPTOR:

Yin-yang appearance. To-and-fro flow in neck.

PEARL:

Small (<2cm) pseudoaneurysms may resolve spontaneously

Page 71: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

TREATMENT:

expectant (for small lesions)

ultrasound graded compression

percutaneous thrombin injection

small needle

500-1000U thrombin

must have short neck, no AVF

surgical repair

stent graft

6

Presentation Title - Subtitle

Page 72: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

77

Case 7: LOWER GI HEMORRHAGE (DIVERTICULAR)

Page 73: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Tc-99 RBC scan

SMA arteriogram - early

SMA arteriogram - late

Page 74: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 75: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 76: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Angiodysplasia

Neoplasia (polyp/carcinoma)

Colitis

7

Presentation Title - Subtitle

Page 77: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points7

Presentation Title - Subtitle

NOTABLE:

divericulosis accounts for 65% of LGI hemorrhage

CLASSIC DESCRIPTOR:

extravasation of contrast, pooling on delayed phase, shape of diverticulum

PEARL:

do not image an unstable patient with lower GI hemorrage – take them straight to angio suite

Page 78: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

MANAGEMENT:

stabilize patient

if stable – image (CTA, Tc99 RBC scan)

if actively bleeding – to angio for diagnosis/treatment

treatment is embolization

superselective coil embolization

particles risk of ischemia

7

Presentation Title - Subtitle

Page 79: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

88

Case 8: TYPE I ENDOLEAK POST EVAR

Page 80: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Endoleak classification

Type I – inadequate seal proximally or distally

Type II – retrograde flow via collateral

Type III – graft failure, component separation

Type IV – porosity of graft

Type V - endotension

8

Presentation Title - Subtitle

Page 81: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Sag 3D volume rendered CTA

Page 82: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Left renal arteryLeft renal artery

Pre-treatment Post-treatment

Page 83: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points8

Presentation Title - Subtitle

NOTABLE:

Type II endoleaks post EVAR are common and usually managed expectantly

Type I endoleaks more common in grafts without suprarenal fixation or in large/short necks

CLASSIC DESCRIPTOR:

contrast outside endograft, within aneurysm sac

PEARL:

Delayed imaging improves sensitivity for detection of endoleak

Page 84: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

TREATMENT:Type 1 endoleak

treated by extension of graft or buttress with balloon expandable stent

Type 2 endoleaktreated by embolizationdirect sac puncture vs. transarterial

Type 3 endoleaknew graft within old graft

Type 4 endoleak, usually intraoperative and resolve spontaneously

Type 5 endoleak – no treatment

8

Presentation Title - Subtitle

Page 85: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

99

Case 9:LEFT UNILATERAL VARICOCELE

Page 86: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Secondary varicocele

- retroperitoneal mass

- renal vein/IVC occlusion

9

Presentation Title - Subtitle

Page 87: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

4mm

Left gonadal venogram

Page 88: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 89: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

post embolization

embolization coils

Left gonadal venogram

Page 90: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points9

Presentation Title - Subtitle

NOTABLE:

common cause of palpable scrotal mass

veins > 3mm on ultrasound are diagnostic

CLASSIC DESCRIPTOR:

“bag of worms” on ultrasound

PEARL:

most often “idiopathic”, look for a cause in cases of isolated right-side varicocele

Page 91: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

TREATMENT:

endovascular (embolization) vs. surgical (ligation)

both are “minimally invasive”

both have comparable outcomes

embolic material of choice is coils for large vessel occlusion

9

Presentation Title - Subtitle

Page 92: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

1010

Case 10: MASSIVE HEMOPTYSIS (ASPERGILLOMA)

Page 93: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Right intercostobronchial trunk arteriogram

R ICBT

Abnormal parenchymal stain

Page 94: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Sarcoid/TB

Neoplasm

Airway trauma

Vasculitis

10

Presentation Title - Subtitle

Page 95: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points10

Presentation Title - Subtitle

NOTABLE:

defined as >500cc hemoptysis in 24 hours

multiple causes, usually blood supply is by hypertrophied bronchial artery

CLASSIC DESCRIPTOR:

hypertrophied bronchial artery with abnormal parenchymal stain +/- shunting to pulmonary artery/vein

NB - active extravasation not commonly seen

PEARL:

mainstay of therapy is bronchial embolization – BEWARE THE ANTERIOR SPINAL ARTERY

Page 96: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points

TREATMENT:

particle embolization of bronchial artery

no coils – won’t be able to treat recurrence

BEWARE THE ANTERIOR SPINAL ARTERYvariable bronchial artery anatomy

most commonly right intercostobronchial trunk, left bronchial artery

10

Presentation Title - Subtitle

Page 97: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points - CLOSING

Sometimes surgery is the answer

Interventional options:

Embolization, covered stent, thrombin

Types of embolic agents:

permanent (PVA, glue, coils) vs temporary (gelfoam)

Coils are akin to surgical ligation

- “proximal” occlusion

- potential for collateral formation

Particles/glue

- “distal” occlusion, capillary/arteriolar level

- no collaterals, risk for ischemia

Presentation Title - Subtitle

Page 98: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASES

Page 99: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 1155 year old male, hepatoma screen

1111

Page 100: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Arterial phase Venous phase

Page 101: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

Potential treatment options?

1111

Page 102: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 12:60 year old male with abdominal pain

1212

Page 103: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Hypoattenuating mass

Page 104: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Probable diagnosis?

What would be your approach to biopsy?

What are the risks of biopsy?

1212

Page 105: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 1357 year old male, right flank pain and fever

1313

Page 106: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 107: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Diagnosis?

How can a radiologist help?

What are the risks of percutaneous intervention?

1212

Page 108: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 1460 year old male, left lower quadrant pain and fever

1414

Page 109: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Is this drainable?

Page 110: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Probable diagnosis?

Is this collection drainable?

What route/guidance method would you choose?

1212

Page 111: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE 15: 70 year old female, fever and right upper quadrant pain

1515

Page 112: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Soft tissue massDuct dilation

Page 113: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Probable diagnosis?

Treatment options?

What kind of tube would you use for percutaneous intervention?

1212

Page 114: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

CASE REVIEW

Page 115: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

1111

Case 11: HEPATOCELLULAR CARCINOMA

Page 116: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Dysplastic nodule

Hemangioma

FNH-like lesion

11

Presentation Title - Subtitle

Page 117: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Arterial phase Venous phase

Page 118: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

RFA electrodePost ablation

Page 119: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points11

Presentation Title - Subtitle

NOTABLE:

Very common in far east, increased incidence in north america

CLASSIC DESCRIPTOR:

Arterially enhancing nodule with washout in cirrhotic liver

PEARL:

Any arterially enhancing lesion >2cm in a cirrhotic liver is HCC until proven otherwise

Only cure is liver transplantation

Page 120: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points11

Presentation Title - Subtitle

TREATMENT:

Only curative treatment for HCC is transplant

Surgical resection for surgical candidates

RFA for non-surgical candidates

+/- lesions ≤ 2.5cm

chemoembolization

radiotherapy

sorafenib

Risks of RFA: hemorrage, infection, bile duct injury, needle tract seeding, colon/GB injury

Page 121: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

1212

Case 12: PANCREATIC ADENOCARCINOMA

Page 122: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Percutaneous biopsy

Page 123: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Pancreatic adenoCa

Focal pancreatitis

Metastasis

12

Presentation Title - Subtitle

Page 124: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points12

Presentation Title - Subtitle

NOTABLE:

most commonly present in pancreatic head.

CLASSIC DESCRIPTOR:

ill-defined hypoattenuating pass pancreatic head

PEARL:

Most unresectable

Page 125: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points12

Presentation Title - Subtitle

PERCUTANEOUS BIOPSY:

ultrasound vs. CT guided

may go transgastric if needed

risks:

hemorrage

infection

tumour seeding very rare

bowel injury

coaxial technique

core biopsy preferred

Page 126: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

1313

Case 13: PYELONEPHRITIS, OBSTRUCTING CALCULUS

Page 127: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 128: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Non-infected hydronephrosis

Pre-existing UPJ obstruction

13

Presentation Title - Subtitle

Page 129: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 130: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points13

Presentation Title - Subtitle

NOTABLE:

99% of renal calculi depicted on non-contrast CT

Most calculi impacted at UVJ, UPJ or pelvic brim

CLASSIC DESCRIPTOR:

radioopaque calculus with associated renal enlargement, perinephric stranding, hydronephrosis/hydroureter

PEARL:

Infected calculi, hydronephrosis in solitary kidney or electrolyte disturbances are indications for urgent management

Page 131: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points13

Presentation Title - Subtitle

TREATMENT:

renal decompression

urgently for sepsis, solitary kidney, electrolyte disturbance

options:

percutaneous nephrostomy/ nephroureterostomy

percutaneous JJ stent

cystoscopic JJ stent

risks of percutaneous therapy

worsening sepsis, hemorrhage/AVF, other organ injury

Page 132: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 133: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

1414

Case 14: DIVERTICULAR ABSCESS

Page 134: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Perforated colon cancer

Abscess from inflammatory bowel disease

14

Presentation Title - Subtitle

Page 135: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Is this drainable?

Page 136: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

18 gauge needle10Fr abscess drain

Page 137: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points14

Presentation Title - Subtitle

NOTABLE:

prevalence of diverticulosis @ 50% after age 70

complications include diverticulitis, fistula, muscular hypertrophy, lower GI bleed

CLASSIC DESCRIPTOR:

rim enahancing fluid collection in sigmoid mesentary, adjacent to inflamed diverticulum

PEARL:

always do elective sigmoidoscopy/colonoscopy to rule out underlying malignancy

Page 138: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points14

Presentation Title - Subtitle

TREATMENT:

medical

antibiotics, often successful for small collections

surgery

two stage – hartman’s with colostomy, then reversal

percutaneous

definitive management

delay surgery to elective, 1-stage procedure

Page 139: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points14

Presentation Title - Subtitle

PERCUTANEOUS TREATMENT:

US guidance – faster, safer

CT guidance – not all lesions can be seen by ultrasound

deep

gas obscuring view

Seldinger vs. Trochar

safer vs. faster, less painful

Tube size – 10 French or bigger for pus, thick bile, pleural fluid

Page 140: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points14

Presentation Title - Subtitle

WHAT IS FRENCH SIZE?!?!?!:

Circumference of tube in mm

French size/3 = diameter

Eg. 8Fr tube is ~ 2.7mm

- suitable for simple fluid

Page 141: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

1515

Case 15: KLATSKIN TUMOUR, BILE DUCT OBSTRUCTION

Page 142: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Soft tissue massDuct dilation

Page 143: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Differential Diagnosis

Cholangiocarcinoma

Biliary calculus

15

Presentation Title - Subtitle

Page 144: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 145: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.
Page 146: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points15

Presentation Title - Subtitle

NOTABLE:

Hilar cholangiocarcinoma, known as klatskin tumour

Often unresectable

CLASSIC DESCRIPTOR:

Hilar soft tissue mass with bilateral biliary obstruction. Lack of communication of left and right sided ducts

PEARL:

Often require biliary drainage to restore bilirubin and allow safe administration of chemotherapy

Page 147: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points15

Presentation Title - Subtitle

TREATMENT:

Medical

Surgical

Endoscopic

plastic stents

can’t be removed without endoscopy

limited access

more appropriate for low lesions

if the GB is distended – ERCP

Percutaneous

Page 148: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points15

Presentation Title - Subtitle

PERCUTANEOUS TREATMENT:

Goal is to decompress as much liver as possible

Goal is internal drainage if possible

Internal/external biliary drainage catheter

minimize manipulation if cholangitis

Either side if right and left side communicate

Right side first vs. bilateral tubes if not

Page 149: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

Key Points – NEEDLES/DRAINS

Presentation Title - Subtitle

Procedures are not without risk

Bleeding, infection, other organ injury

Internal drainage always desirable

US faster, safer when possible

Seldinger vs. trochar

- safer, slower, more painful

Page 150: VASCULAR/ INTERVENTIONAL Dr. Jeff Jaskolka University of Toronto.

THANK YOU